• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西亚马逊地区一系列完全尸检中与 COVID-19 相关的肺曲霉病。

COVID-19-Associated Pulmonary Aspergillosis in a Series of Complete Autopsies from the Brazilian Amazon.

机构信息

Instituto de Pesquisa Clínica Carlos Borborema, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.

Instituto Leônidas & Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.

出版信息

Am J Trop Med Hyg. 2022 Jan 7;106(2):571-573. doi: 10.4269/ajtmh.21-1009.

DOI:10.4269/ajtmh.21-1009
PMID:34996046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8832933/
Abstract

Between April and July 2020, and, therefore, prior to the broad recommendation of corticosteroids for severe COVID-19, a total of 50 full autopsies were performed in Manaus. We confirmed two invasive cases of aspergillosis through histopathology and gene sequencing (4%) in our autopsy series. The confirmed invasive aspergillosis incidence seems much lower than expected based on the "probable and possible" definitions, and an individualized approach should be considered for each country scenario. Interestingly, a prolonged length of stay in the intensive care unit was not observed in any of the cases. Timely diagnosis and treatment of fungal infection can reduce mortality rates.

摘要

2020 年 4 月至 7 月期间,即在广泛推荐皮质类固醇治疗重症 COVID-19 之前,我们在马瑙斯总共进行了 50 例全尸解剖。我们通过组织病理学和基因测序在尸检系列中确认了两例侵袭性曲霉菌病(4%)。基于“可能”和“很可能”的定义,确认的侵袭性曲霉菌病发病率似乎远低于预期,每个国家的情况都应考虑采取个体化方法。有趣的是,我们没有在任何病例中观察到重症监护病房住院时间延长。及时诊断和治疗真菌感染可以降低死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df58/8832933/6208aa6b11f2/tpmd211009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df58/8832933/6208aa6b11f2/tpmd211009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df58/8832933/6208aa6b11f2/tpmd211009f1.jpg

相似文献

1
COVID-19-Associated Pulmonary Aspergillosis in a Series of Complete Autopsies from the Brazilian Amazon.巴西亚马逊地区一系列完全尸检中与 COVID-19 相关的肺曲霉病。
Am J Trop Med Hyg. 2022 Jan 7;106(2):571-573. doi: 10.4269/ajtmh.21-1009.
2
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.COVID-19 相关肺曲霉病:一项前瞻性单中心双病例系列研究。
Mycoses. 2021 Apr;64(4):457-464. doi: 10.1111/myc.13254. Epub 2021 Feb 16.
3
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学:一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
4
Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.COVID-19 相关肺曲霉病的发病率和死亡率:系统评价和荟萃分析。
Mycoses. 2021 Sep;64(9):993-1001. doi: 10.1111/myc.13292. Epub 2021 May 6.
5
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.免疫功能正常患者的侵袭性曲霉病和冠状病毒病致死。
Emerg Infect Dis. 2020 Jul;26(7):1636-1637. doi: 10.3201/eid2607.201603. Epub 2020 Jun 21.
6
Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.COVID-19 患者中确诊的黄曲霉菌性肺曲霉病:病例报告及文献复习。
Mycoses. 2021 Aug;64(8):809-816. doi: 10.1111/myc.13255. Epub 2021 Mar 2.
7
COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis?美国的新型冠状病毒肺炎相关肺曲霉病:是罕见还是我们漏诊了?
J Clin Microbiol. 2021 Sep 20;59(10):e0113521. doi: 10.1128/JCM.01135-21. Epub 2021 Jul 21.
8
SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale.SARS-CoV-2 相关免疫失调与 COVID-19 相关肺曲霉病(CAPA):一个警示故事。
Int J Mol Sci. 2022 Mar 17;23(6):3228. doi: 10.3390/ijms23063228.
9
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).COVID-19 相关危重症患者的肺部曲霉病。
Med Mycol. 2021 Jan 4;59(1):110-114. doi: 10.1093/mmy/myaa078.
10
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.深圳市一家三级保健中心的 COVID-19 相关肺曲霉病。
J Infect Public Health. 2022 Feb;15(2):222-227. doi: 10.1016/j.jiph.2021.12.015. Epub 2022 Jan 6.

引用本文的文献

1
Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study.重症监护病房中2019冠状病毒病相关真菌感染的流行病学:一项单中心回顾性研究。
Mycopathologia. 2025 Jan 21;190(1):16. doi: 10.1007/s11046-025-00928-8.
2
A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.基于病理学的流感和 COVID-19 相关肺曲霉病病例系列:证据就在组织中。
Am J Respir Crit Care Med. 2023 Aug 1;208(3):301-311. doi: 10.1164/rccm.202208-1570OC.
3
Autopsy Findings of Severe COVID-19 Pneumonia Combined with Pulmonary Aspergillosis, Pneumothorax, and Pulmonary Thromboembolisms.

本文引用的文献

1
Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.与新冠病毒感染后糖尿病酮症酸中毒相关的致命性鼻眶脑毛霉菌病感染
Rev Soc Bras Med Trop. 2021 Jul 12;54:e03582021. doi: 10.1590/0037-8682-0358-2021. eCollection 2021.
2
Invasive mould disease in fatal COVID-19: a systematic review of autopsies.COVID-19 致死患者的侵袭性霉菌病:尸检的系统回顾。
Lancet Microbe. 2021 Aug;2(8):e405-e414. doi: 10.1016/S2666-5247(21)00091-4. Epub 2021 Jun 23.
3
Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
COVID-19 重症肺炎合并肺曲霉病、气胸、肺血栓栓塞症的尸检结果。
Am J Case Rep. 2023 May 24;24:e939251. doi: 10.12659/AJCR.939251.
4
Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data.危重症患者中诊断新型冠状病毒肺炎相关肺曲霉病的挑战:病例定义与尸检数据之间的关系
J Fungi (Basel). 2022 Aug 23;8(9):894. doi: 10.3390/jof8090894.
COVID-19 相关肺曲霉病的发病率和死亡率:系统评价和荟萃分析。
Mycoses. 2021 Sep;64(9):993-1001. doi: 10.1111/myc.13292. Epub 2021 May 6.
4
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病的诊断困境
Lancet Infect Dis. 2021 Jun;21(6):766-767. doi: 10.1016/S1473-3099(21)00060-8. Epub 2021 Mar 1.
5
Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia.重症肺炎COVID-19患者中机会性侵袭性曲霉病的患病率。
Mycoses. 2021 Feb;64(2):144-151. doi: 10.1111/myc.13219. Epub 2020 Dec 3.
6
Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report.COVID-19 患者的血管内皮功能障碍和血栓形成——简要报告。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2404-2407. doi: 10.1161/ATVBAHA.120.314860. Epub 2020 Aug 7.
7
Confirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem management.确诊侵袭性肺曲霉病和 COVID-19:尸检结果对支持生前治疗的价值。
Rev Soc Bras Med Trop. 2020;53:e20200401. doi: 10.1590/0037-8682-0401-2020. Epub 2020 Jul 3.
8
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎(COVID-19)重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
9
Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.超声引导下微创尸检评估COVID-19患者的肺部和全身受累情况。
Histopathology. 2020 Aug;77(2):186-197. doi: 10.1111/his.14160. Epub 2020 Jul 24.
10
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病:一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.